Temporal Trends in In-Hospital Outcomes Following Unprotected Left-Main Percutaneous Coronary Intervention: An Analysis of 14 522 Cases From British Cardiovascular Intervention Society Database 2009 to 2017.


Journal

Circulation. Cardiovascular interventions
ISSN: 1941-7632
Titre abrégé: Circ Cardiovasc Interv
Pays: United States
ID NLM: 101499602

Informations de publication

Date de publication:
01 2023
Historique:
entrez: 17 1 2023
pubmed: 18 1 2023
medline: 20 1 2023
Statut: ppublish

Résumé

Percutaneous coronary intervention (PCI) is increasingly used as a treatment option for unprotected left main stem artery (unprotected left main stem percutaneous intervention) disease. However, whether patient outcomes have improved over time is uncertain. Using the United Kingdom national PCI database, we studied all patients undergoing unprotected left main stem percutaneous intervention between 2009 and 2017. We excluded patients who presented with ST-segment-elevation, cardiogenic shock, and with an emergency indication for PCI. Between 2009 and 2017, in the study-indicated population, 14 522 unprotected left main stem percutaneous intervention procedures were performed. Significant temporal changes in baseline demographics were observed with increasing patient age and comorbid burden. Procedural complexity increased over time, with the number of vessels treated, bifurcation PCI, number of stents used, and use of intravascular imaging and rotational atherectomy increased significantly through the study period. After adjustment for baseline differences, there were significant temporal reductions in the occurrence of peri-procedural myocardial infarction (P<0.001 for trend), in-hospital major adverse cardiac or cerebrovascular events (P<0.001 for trend), and acute procedural complications (P<0.001 for trend). In multivariable analysis examining the associates of in-hospital major adverse cardiac or cerebrovascular events, while age per year (odds ratio, 1.02 [95% CIs, 1.01-1.03]), female sex (odds ratio, 1.47 [1.19-1.82]), 3 or more stents (odds ratio, 1.67 [05% [1.02-2.67]), and patient comorbidity were associated with higher rates of in-hospital major adverse cardiac or cerebrovascular events, by contrast use of intravascular imaging (odds ratio, 0.56 [0.45-0.70]), and year of PCI (odds ratio, 0.63 [0.46-0.87]) were associated with lower rates of in-hospital major adverse cardiac or cerebrovascular events. Despite trends for increased patient and procedural complexity, in-hospital patient outcomes have improved after unprotected left main stem percutaneous intervention over time.

Sections du résumé

BACKGROUND
Percutaneous coronary intervention (PCI) is increasingly used as a treatment option for unprotected left main stem artery (unprotected left main stem percutaneous intervention) disease. However, whether patient outcomes have improved over time is uncertain.
METHODS
Using the United Kingdom national PCI database, we studied all patients undergoing unprotected left main stem percutaneous intervention between 2009 and 2017. We excluded patients who presented with ST-segment-elevation, cardiogenic shock, and with an emergency indication for PCI.
RESULTS
Between 2009 and 2017, in the study-indicated population, 14 522 unprotected left main stem percutaneous intervention procedures were performed. Significant temporal changes in baseline demographics were observed with increasing patient age and comorbid burden. Procedural complexity increased over time, with the number of vessels treated, bifurcation PCI, number of stents used, and use of intravascular imaging and rotational atherectomy increased significantly through the study period. After adjustment for baseline differences, there were significant temporal reductions in the occurrence of peri-procedural myocardial infarction (P<0.001 for trend), in-hospital major adverse cardiac or cerebrovascular events (P<0.001 for trend), and acute procedural complications (P<0.001 for trend). In multivariable analysis examining the associates of in-hospital major adverse cardiac or cerebrovascular events, while age per year (odds ratio, 1.02 [95% CIs, 1.01-1.03]), female sex (odds ratio, 1.47 [1.19-1.82]), 3 or more stents (odds ratio, 1.67 [05% [1.02-2.67]), and patient comorbidity were associated with higher rates of in-hospital major adverse cardiac or cerebrovascular events, by contrast use of intravascular imaging (odds ratio, 0.56 [0.45-0.70]), and year of PCI (odds ratio, 0.63 [0.46-0.87]) were associated with lower rates of in-hospital major adverse cardiac or cerebrovascular events.
CONCLUSIONS
Despite trends for increased patient and procedural complexity, in-hospital patient outcomes have improved after unprotected left main stem percutaneous intervention over time.

Identifiants

pubmed: 36649390
doi: 10.1161/CIRCINTERVENTIONS.122.012350
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e012350

Auteurs

Tim Kinnaird (T)

Department of Cardiology, University Hospital of Wales, Cardiff, United Kingdom (T.K., S.G., V.F., M.P., L.B., P.D., R.A., A.S.).
Keele Cardiovascular Research Group, Institute of Applied Clinical Sciences, University of Keele, Stoke-on-Trent, United Kingdom (T.K., M.A.M.).

Sean Gallagher (S)

Department of Cardiology, University Hospital of Wales, Cardiff, United Kingdom (T.K., S.G., V.F., M.P., L.B., P.D., R.A., A.S.).

Vasim Farooq (V)

Department of Cardiology, University Hospital of Wales, Cardiff, United Kingdom (T.K., S.G., V.F., M.P., L.B., P.D., R.A., A.S.).

Majd Protty (M)

Department of Cardiology, University Hospital of Wales, Cardiff, United Kingdom (T.K., S.G., V.F., M.P., L.B., P.D., R.A., A.S.).

Liam Back (L)

Department of Cardiology, University Hospital of Wales, Cardiff, United Kingdom (T.K., S.G., V.F., M.P., L.B., P.D., R.A., A.S.).

Peadar Devlin (P)

Department of Cardiology, University Hospital of Wales, Cardiff, United Kingdom (T.K., S.G., V.F., M.P., L.B., P.D., R.A., A.S.).

Richard Anderson (R)

Department of Cardiology, University Hospital of Wales, Cardiff, United Kingdom (T.K., S.G., V.F., M.P., L.B., P.D., R.A., A.S.).

Andrew Sharp (A)

Department of Cardiology, University Hospital of Wales, Cardiff, United Kingdom (T.K., S.G., V.F., M.P., L.B., P.D., R.A., A.S.).

Peter Ludman (P)

Institute of Cardiovascular Sciences, Birmingham University, United Kingdom (P.L.).

Samuel Copt (S)

Division of Statistics, Biosensors SA, Morges, Switzerland (S.C.).

Mamas A Mamas (MA)

Department of Cardiology, Royal Stoke Hospital, UHNM, Stoke-on-Trent, United Kingdom (M.A.M.).
Keele Cardiovascular Research Group, Institute of Applied Clinical Sciences, University of Keele, Stoke-on-Trent, United Kingdom (T.K., M.A.M.).

Nick Curzen (N)

Department of Cardiology, University Hospital NHS Trust, Southampton, United Kingdom (N.C.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH